Accordingly, SIL1 deficiency enhances ALS pathology, whereas SIL1 overexpression affords significant neuroprotection related to improved ER proteostasis and reduced SOD1 aggregation (reviewed in Rozas et al., 2017). Here, SOD1 is linked to amyotrophic lateral sclerosis.